Ganymed Pharmaceuticals GmbH;TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnuetzige GmbH
发明人:
SAHIN, Ugur,TUERECI, OEzlem,MITNACHT-KRAUS, Rita,JACOBS, Stefan,UTSCH, Magdalena,HEINZ, Cornelia,STADLER, Christiane Regina
申请号：
HUE13724523
公开号：
HUE036000T2
申请日:
2013.05.21
申请国别(地区):
HU
年份:
2018
代理人:
摘要：
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
